Skip to main content

What the FDA labels say about taking them together

Darunavir and phenobarbital

Darunavir's FDA label of August 29, 2025 names phenobarbital in its drug interactions section; the phenobarbital labels PlainMeds reads (2) do not name darunavir. The darunavir label: “Phenytoin and phenobarbital levels should be monitored when co-administering with PREZISTA/ritonavir.”

Check it at the source: the darunavir FDA label on DailyMed (effective August 29, 2025, Janssen Products LP); the phenobarbital FDA label on DailyMed (effective August 27, 2026).

What does the darunavir label say about phenobarbital?

Darunavir label, drug interactions

Concomitant Drug Class Drug Name Examples: phenobarbital, phenytoin; Effect on Concentration of Darunavir Or Concomitant Drug: ↔ darunavir ↓ phenytoin ↓ phenobarbital; Clinical Comment: Phenytoin and phenobarbital levels should be monitored when co-administering with PREZISTA/ritonavir.

Source: FDA drug label (PREZISTA), Janssen Products LP, effective August 29, 2025 (SPL set 814301f9-c990-46a5-b481-2879a521a16f), via openFDA; the full label on DailyMed

What does the phenobarbital label say about darunavir?

Phenobarbital's label (effective August 27, 2026) and its 1 other brand-application label do not name darunavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenobarbital), Chartwell RX, LLC, effective August 27, 2026 (SPL set 74428144-fb24-40a5-a670-3b876e2d116c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

13Darunavir generic labelers
0Phenobarbital generic labelers
DarunavirPhenobarbital
Labeled forHIVSeizures and epilepsy
Boxed warningNoNo
Pharmacy cost (NADAC)$1.16 per tablet 600 mg tablet$0.213 per tablet 100 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?